Chang, C.; Zhang, Y.; Kuo, Y.C.; Du, M.; Roh, K.; Gahler, R.; Ibi, A.; Solnier, J.
Novel Micellar Formulation of Silymarin (Milk Thistle) with Enhanced Bioavailability in a Double-Blind, Randomized, Crossover Human Trial. Pharmaceutics 2025, 17, 880.
https://doi.org/10.3390/pharmaceutics17070880
AMA Style
Chang C, Zhang Y, Kuo YC, Du M, Roh K, Gahler R, Ibi A, Solnier J.
Novel Micellar Formulation of Silymarin (Milk Thistle) with Enhanced Bioavailability in a Double-Blind, Randomized, Crossover Human Trial. Pharmaceutics. 2025; 17(7):880.
https://doi.org/10.3390/pharmaceutics17070880
Chicago/Turabian Style
Chang, Chuck, Yiming Zhang, Yun Chai Kuo, Min Du, Kyle Roh, Roland Gahler, Afoke Ibi, and Julia Solnier.
2025. "Novel Micellar Formulation of Silymarin (Milk Thistle) with Enhanced Bioavailability in a Double-Blind, Randomized, Crossover Human Trial" Pharmaceutics 17, no. 7: 880.
https://doi.org/10.3390/pharmaceutics17070880
APA Style
Chang, C., Zhang, Y., Kuo, Y. C., Du, M., Roh, K., Gahler, R., Ibi, A., & Solnier, J.
(2025). Novel Micellar Formulation of Silymarin (Milk Thistle) with Enhanced Bioavailability in a Double-Blind, Randomized, Crossover Human Trial. Pharmaceutics, 17(7), 880.
https://doi.org/10.3390/pharmaceutics17070880
